Literature DB >> 33498210

Mechanisms Applied by Protein Inhibitors to Inhibit Cysteine Proteases.

Livija Tušar1,2, Aleksandra Usenik1,2, Boris Turk1,3,4, Dušan Turk1,2.   

Abstract

Protein inhibitors of proteases are an important tool of nature to regulate and control proteolysis in living organisms under physiological and pathological conditions. In this review, we analyzed the mechanisms of inhibition of cysteine proteases on the basis of structural information and compiled kinetic data. The gathered structural data indicate that the protein fold is not a major obstacle for the evolution of a protease inhibitor. It appears that nature can convert almost any starting fold into an inhibitor of a protease. In addition, there appears to be no general rule governing the inhibitory mechanism. The structural data make it clear that the "lock and key" mechanism is a historical concept with limited validity. However, the analysis suggests that the shape of the active site cleft of proteases imposes some restraints. When the S1 binding site is shaped as a pocket buried in the structure of protease, inhibitors can apply substrate-like binding mechanisms. In contrast, when the S1 binding site is in part exposed to solvent, the substrate-like inhibition cannot be employed. It appears that all proteases, with the exception of papain-like proteases, belong to the first group of proteases. Finally, we show a number of examples and provide hints on how to engineer protein inhibitors.

Entities:  

Keywords:  compiled kinetic data; cysteine proteases inhibitors; mechanisms of inhibition; structural-based inhibition

Mesh:

Substances:

Year:  2021        PMID: 33498210      PMCID: PMC7863939          DOI: 10.3390/ijms22030997

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  189 in total

1.  Increase in catheptic activity and appearance of phagocytes in the white muscle of chum salmon during spawning migration.

Authors:  M Yamashita; S Konagaya
Journal:  Biomed Biochim Acta       Date:  1991

2.  Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes.

Authors:  M Nakada; A Yamada; T Takino; H Miyamori; T Takahashi; J Yamashita; H Sato
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

3.  Structure-function studies of an engineered scaffold protein derived from Stefin A. II: Development and applications of the SQT variant.

Authors:  Lukas Kurt Josef Stadler; Toni Hoffmann; Darren Charles Tomlinson; Qifeng Song; Tracy Lee; Michael Busby; Yvonne Nyathi; Elisenda Gendra; Christian Tiede; Keith Flanagan; Simon J Cockell; Anil Wipat; Colin Harwood; Simon D Wagner; Margaret A Knowles; Jason J Davis; Neil Keegan; Paul Ko Ferrigno
Journal:  Protein Eng Des Sel       Date:  2011-05-25       Impact factor: 1.650

4.  Structural basis for the regulation of cysteine-protease activity by a new class of protease inhibitors in Plasmodium.

Authors:  Guido Hansen; Anna Heitmann; Tina Witt; Honglin Li; Hualiang Jiang; Xu Shen; Volker T Heussler; Annika Rennenberg; Rolf Hilgenfeld
Journal:  Structure       Date:  2011-07-13       Impact factor: 5.006

5.  A novel cysteine protease inhibitor of the egg of chum salmon, containing a cysteine-rich thyroglobulin-like motif.

Authors:  M Yamashita; S Konagaya
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

6.  Biochemical characterization of human cathepsin X revealed that the enzyme is an exopeptidase, acting as carboxymonopeptidase or carboxydipeptidase.

Authors:  I Klemencic; A K Carmona; M H Cezari; M A Juliano; L Juliano; G Guncar; D Turk; I Krizaj; V Turk; B Turk
Journal:  Eur J Biochem       Date:  2000-09

7.  Target protease specificity of the viral serpin CrmA. Analysis of five caspases.

Authors:  Q Zhou; S Snipas; K Orth; M Muzio; V M Dixit; G S Salvesen
Journal:  J Biol Chem       Date:  1997-03-21       Impact factor: 5.157

8.  Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-1 domain.

Authors:  B Lenarcic; A Ritonja; B Strukelj; B Turk; V Turk
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

9.  A single BIR domain of XIAP sufficient for inhibiting caspases.

Authors:  R Takahashi; Q Deveraux; I Tamm; K Welsh; N Assa-Munt; G S Salvesen; J C Reed
Journal:  J Biol Chem       Date:  1998-04-03       Impact factor: 5.157

10.  The structure of a complex of recombinant hirudin and human alpha-thrombin.

Authors:  T J Rydel; K G Ravichandran; A Tulinsky; W Bode; R Huber; C Roitsch; J W Fenton
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

View more
  2 in total

Review 1.  A Review: Natural and Synthetic Compounds Targeting Entamoeba histolytica and Its Biological Membrane.

Authors:  Nurhana Jasni; Syazwan Saidin; Norsyahida Arifin; Daruliza Kernain Azman; Lai Ngit Shin; Nurulhasanah Othman
Journal:  Membranes (Basel)       Date:  2022-04-01

Review 2.  Proteases and Their Potential Role as Biomarkers and Drug Targets in Dry Eye Disease and Ocular Surface Dysfunction.

Authors:  Alba Ramos-Llorca; Camilla Scarpellini; Koen Augustyns
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.